Lynea Murphy

533 total citations
18 papers, 413 citations indexed

About

Lynea Murphy is a scholar working on Molecular Biology, Pharmacology and Health, Toxicology and Mutagenesis. According to data from OpenAlex, Lynea Murphy has authored 18 papers receiving a total of 413 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 4 papers in Pharmacology and 3 papers in Health, Toxicology and Mutagenesis. Recurrent topics in Lynea Murphy's work include Pharmacogenetics and Drug Metabolism (4 papers), Heat shock proteins research (4 papers) and Effects and risks of endocrine disrupting chemicals (3 papers). Lynea Murphy is often cited by papers focused on Pharmacogenetics and Drug Metabolism (4 papers), Heat shock proteins research (4 papers) and Effects and risks of endocrine disrupting chemicals (3 papers). Lynea Murphy collaborates with scholars based in United States, India and Taiwan. Lynea Murphy's co-authors include Kevin D. Sarge, Donald C. Wilkerson, Stephen Nesnow, Hongyan Xing, Hollie S. Skaggs, Roland Hilgarth, Tanya Moore, William T. Padgett, Charles E. Wood and Susan Hester and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Lynea Murphy

17 papers receiving 402 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lynea Murphy United States 12 277 75 44 41 40 18 413
Swapan Samanta India 12 222 0.8× 94 1.3× 33 0.8× 40 1.0× 67 1.7× 28 498
Stefan Stinchcombe Germany 11 130 0.5× 152 2.0× 43 1.0× 136 3.3× 75 1.9× 14 374
Hollie S. Skaggs United States 7 351 1.3× 29 0.4× 22 0.5× 43 1.0× 52 1.3× 9 479
Sebastian Canzler Germany 9 264 1.0× 66 0.9× 29 0.7× 35 0.9× 28 0.7× 15 414
Werner Bomann United States 9 196 0.7× 154 2.1× 48 1.1× 77 1.9× 31 0.8× 12 370
Shrey Jain India 8 229 0.8× 92 1.2× 77 1.8× 29 0.7× 26 0.7× 10 376
Valentina Rubio United States 9 250 0.9× 33 0.4× 16 0.4× 44 1.1× 16 0.4× 10 349
T. Manoharan India 12 321 1.2× 29 0.4× 87 2.0× 17 0.4× 49 1.2× 48 465
Yin‐Chang Liu Taiwan 11 233 0.8× 43 0.6× 38 0.9× 27 0.7× 41 1.0× 31 386
Lan Lin China 15 448 1.6× 71 0.9× 94 2.1× 15 0.4× 29 0.7× 32 616

Countries citing papers authored by Lynea Murphy

Since Specialization
Citations

This map shows the geographic impact of Lynea Murphy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lynea Murphy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lynea Murphy more than expected).

Fields of papers citing papers by Lynea Murphy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lynea Murphy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lynea Murphy. The network helps show where Lynea Murphy may publish in the future.

Co-authorship network of co-authors of Lynea Murphy

This figure shows the co-authorship network connecting the top 25 collaborators of Lynea Murphy. A scholar is included among the top collaborators of Lynea Murphy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lynea Murphy. Lynea Murphy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Murphy, Lynea, Matthew J. LeBaron, Kamin J. Johnson, et al.. (2021). Bridging Sex-Specific Differences in the CAR-Mediated Hepatocarcinogenesis of Nitrapyrin Using Molecular and Apical Endpoints. SHILAP Revista de lepidopterología. 3. 766196–766196. 2 indexed citations
2.
Bianchi, Enrica, Lynea Murphy, Jessica J. Howell, et al.. (2020). A rat subchronic study transcriptional point of departure estimates a carcinogenicity study apical point of departure. Food and Chemical Toxicology. 147. 111869–111869. 14 indexed citations
3.
LaRocca, Jessica, Reza J. Rasoulpour, B. Bhaskar Gollapudi, et al.. (2017). Integration of novel approaches demonstrates simultaneous metabolic inactivation and CAR-mediated hepatocarcinogenesis of a nitrification inhibitor. Toxicology Reports. 4. 586–597. 12 indexed citations
4.
Miousse, Isabelle R., Lynea Murphy, Jinchun Sun, et al.. (2017). Dose-response analysis of epigenetic, metabolic, and apical endpoints after short-term exposure to experimental hepatotoxicants. Food and Chemical Toxicology. 109(Pt 1). 690–702. 20 indexed citations
5.
Settivari, Raja S., Nicholas Ball, Lynea Murphy, et al.. (2015). Predicting the future: opportunities and challenges for the chemical industry to apply 21st-century toxicity testing.. PubMed. 54(2). 214–23. 15 indexed citations
6.
Terry, Claire, Lynea Murphy, Manoj Aggarwal, et al.. (2014). Integrating toxicokinetics into the human health risk assessment process for agrochemicals: Halauxifen-methyl. Toxicology Letters. 229. S218–S219. 1 indexed citations
7.
Sura, Radhakrishna, et al.. (2014). Concurrent evaluation of general, immune, and genetic toxicity endpoints as part of an integrated testing strategy. Environmental and Molecular Mutagenesis. 55(7). 530–541. 2 indexed citations
8.
Murphy, Lynea, Tanya Moore, & Stephen Nesnow. (2012). Propiconazole-enhanced hepatic cell proliferation is associated with dysregulation of the cholesterol biosynthesis pathway leading to activation of Erk1/2 through Ras farnesylation. Toxicology and Applied Pharmacology. 260(2). 146–154. 20 indexed citations
9.
Hester, Susan, Tanya Moore, William T. Padgett, et al.. (2012). The Hepatocarcinogenic Conazoles: Cyproconazole, Epoxiconazole, and Propiconazole Induce a Common Set of Toxicological and Transcriptional Responses. Toxicological Sciences. 127(1). 54–65. 66 indexed citations
10.
Nesnow, Stephen, Rachel D. Grindstaff, Guy R. Lambert, et al.. (2011). Propiconazole increases reactive oxygen species levels in mouse hepatic cells in culture and in mouse liver by a cytochrome P450 enzyme mediated process. Chemico-Biological Interactions. 194(1). 79–89. 38 indexed citations
11.
Murphy, Lynea, Tanya Moore, & Stephen Nesnow. (2010). Abstract 1076: Reversible effect of all-trans-retinoic acid on AML12 hepatocyte proliferation and cell cycle progression. Cancer Research. 70(8_Supplement). 1076–1076. 1 indexed citations
12.
Wilkerson, Donald C., Lynea Murphy, & Kevin D. Sarge. (2008). Interaction of HSF1 and HSF2 with the Hspa1b Promoter in Mouse Epididymal Spermatozoa1. Biology of Reproduction. 79(2). 283–288. 20 indexed citations
13.
Murphy, Lynea, Donald C. Wilkerson, Yiling Hong, & Kevin D. Sarge. (2008). PRC1 associates with the hsp70i promoter and interacts with HSF2 during mitosis. Experimental Cell Research. 314(11-12). 2224–2230. 9 indexed citations
14.
Murphy, Lynea & Kevin D. Sarge. (2008). Phosphorylation of CAP-G is required for its chromosomal DNA localization during mitosis. Biochemical and Biophysical Research Communications. 377(3). 1007–1011. 33 indexed citations
15.
Skaggs, Hollie S., Hongyan Xing, Donald C. Wilkerson, et al.. (2007). HSF1-TPR Interaction Facilitates Export of Stress-induced HSP70 mRNA. Journal of Biological Chemistry. 282(47). 33902–33907. 38 indexed citations
16.
Murphy, Lynea, et al.. (2007). INVESTIGATING THE ROLE OF HSF2 DURING SPERMATOGENESIS. Biology of Reproduction. 77(Suppl_1). 192–192. 1 indexed citations
18.
Hilgarth, Roland, Lynea Murphy, Hollie S. Skaggs, et al.. (2004). Regulation and Function of SUMO Modification. Journal of Biological Chemistry. 279(52). 53899–53902. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026